| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |